Knight Therapeutics Inc News

Knight Therapeutics Inc. (TSE:GUD) Most Popular Amongst Individual Investors Who Own 41% of the Shares, Institutions Hold 24%

Yahoo FinanceDec 27, 2024 05:28 ET

Knight Therapeutics Says Health Canada Accepts ADHD Drug Application for Review

MT NewswiresDec 16, 2024 16:50 ET

Express News | Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (Viloxazine) in Canada

ReutersDec 16, 2024 16:30 ET

Knight Therapeutics Announces Filing of New Drug Submission for Qelbree (Viloxazine) in Canada

GlobeNewswireDec 16, 2024 16:30 ET

Knight Therapeutics Announces Regulatory Approval of TAVALISSE in Mexico

GlobeNewswireDec 12, 2024 07:30 ET

Knight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 9, 2024 06:53 ET · Conference Call

Knight Therapeutics Inc (KHTRF) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Margin ...

InvestingNov 7, 2024 20:14 ET

Express News | Knight Therapeutics Announces Approval of Minjuvi® (Tafasitamab) in Mexico

ReutersOct 15, 2024 08:30 ET

Knight Therapeutics Announces Approval of Minjuvi (Tafasitamab) in Mexico

GlobeNewswireOct 15, 2024 08:30 ET

Knight Therapeutics Inc. Places No. 397 on The Globe and Mail's Sixth Annual Ranking of Canada's Top Growing Companies

GlobeNewswireSep 27, 2024 10:22 ET

Knight Therapeutics Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now

Yahoo FinanceAug 11, 2024 09:03 ET

Earnings Flash: Knight Therapeutics Q2 Revenue $95.5 Million, Up 6% From 2023

MT NewswiresAug 8, 2024 07:41 ET

Knight Therapeutics Brief: Delivered Record Revenues of $95.573 Million, an Increase of 6% Over the Same Period in Prior Year

MT NewswiresAug 8, 2024 07:36 ET

Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call

GlobeNewswireAug 1, 2024 07:30 ET

Knight Therapeutics Inc. (TSE:GUD) Stock Most Popular Amongst Individual Investors Who Own 40%, While Private Companies Hold 25%

Yahoo FinanceJul 13, 2024 10:06 ET

Knight Therapeutics Inc: INTERIM MDA FR

SEDARMay 16, 2024 13:10 ET · Announcements

Knight Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT FR

SEDARMay 16, 2024 13:08 ET · Announcements

Earnings Call Summary | KNIGHT THERAPEUTICS INC(KHTRF.US) Q1 2024 Earnings Conference

moomoo AIMay 11, 2024 15:33 ET · Conference Call

Knight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1

MT NewswiresMay 9, 2024 11:02 ET

Knight Therapeutics Inc: INTERIM MDA EN

SEDARMay 9, 2024 07:48 ET · Announcements